Subgroup Analysis of the MARINA Study of Ranibizumab in Neovascular Age-Related Macular Degeneration
Top Cited Papers
- 1 February 2007
- journal article
- research article
- Published by Elsevier in Ophthalmology
- Vol. 114 (2) , 246-252
- https://doi.org/10.1016/j.ophtha.2006.10.045
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Ranibizumab versus Verteporfin for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2006
- Ranibizumab for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2006
- Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report no. 1American Journal of Ophthalmology, 2003
- Increased expression of angiogenic growth factors in age-related maculopathyBritish Journal of Ophthalmology, 1997
- Basic Fibroblast Growth Factor and Vascular Endothelial Growth Factor Are Present in Epiretinal and Choroidal Neovascular MembranesAmerican Journal of Ophthalmology, 1996